News
Biogen will invest an additional $2 billion in its existing manufacturing in North Carolina, the drugmaker said on Monday, as ...
Biogen has announced plans to invest an additional $2bn in Research Triangle Park (RTP) in the US state of North Carolina. The latest manufacturing investment will support the ongoing development of ...
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date ...
Biogen Inc. is investing $2 billion in its North Carolina RTP site, expanding manufacturing amid tariff talks.
Biogen will invest an extra $2 billion to expand its RTP facilities, focusing on AI-driven manufacturing and late-stage ...
Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation ...
Explore more
The biotech is planning to expand antisense oligonucleotide capabilities and infrastructure on campuses that already produce ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results